Results 211 to 220 of about 1,649,172 (225)

Abstract PR014: Robust disease monitoring using CSF liquid biopsies collected from children undergoing cellular therapy for malignant central nervous system tumors

open access: closedClinical Cancer Research
Abstract Background: Central nervous system (CNS) tumors remain the leading cause of cancer-related mortality in children, necessitating more effective treatment options. Chimeric Antigen Receptor T-cells (CAR-T) have emerged as a promising strategy to treat CNS tumors, with B7H3 (CD276) representing an attractive target due to its high ...
Anna Kostecka   +10 more
openalex   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL

Cancers, 2021
Alexander Baraniskin, Roland Schroers
exaly  

CSF liquid biopsy in patients with difusse glioma. Systematic review

Antecedents: Els gliomes difusos són els tumors primaris més comuns al sistema nerviós central, amb una baixa taxa de supervivència. La biòpsia tumoral és el mètode actual per demostrar-los, però presenta riscos i no sempre representa totes les característiques moleculars del tumor. Es proposa la biòpsia líquida com una alternativa menys invasiva i més
openaire   +1 more source

CSF Biopsy in Glioma: A Brief Review

Methods in Molecular Biology, 2023
Liang Gong
exaly  

Cell-Free Tumor DNA (cf-tDNA) Liquid Biopsy: Current Methods and Use in Brain Tumor Immunotherapy

Frontiers in Immunology, 2022
Karthik Ravi   +2 more
exaly  

Liquid biopsy for monitoring medulloblastoma

2022
Robert Eibl, Markus Schneemann
exaly  

Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients’ management: Close to the clinic?

Critical Reviews in Oncology/Hematology, 2020
Lorenzo Bello   +2 more
exaly  

Home - About - Disclaimer - Privacy